Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, remains a significant global health issue. Despite advancements in diagnostic tools and therapeutic strategies, challenges persist in clinical practice. This article aims to provide an updated approach to the diagnosis and management of enteric fever.
Accurate diagnosis of enteric fever is critical. Traditional methods, such as blood culture, remain the gold standard but suffer from sensitivity issues. Recent advances in molecular diagnostics, including PCR-based tests, offer improved sensitivity and specificity. Serological tests like Widal and Typhidot are commonly used in resource-limited settings, but their reliability is questionable due to cross-reactivity and variability in antibody response. Therefore, integrating these methods with clinical suspicion and epidemiological data is crucial.
Antimicrobial therapy is the cornerstone of enteric fever management. Resistance to first-line drugs, such as chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole, has led to the use of fluoroquinolones. However, the emergence of fluoroquinolone-resistant strains necessitates alternative therapies. Third-generation cephalosporins and azithromycin have shown promising results. The choice of antimicrobial should be guided by local susceptibility patterns and patient characteristics.
Supportive care, including hydration and symptom management, is crucial. Vaccination remains the most effective preventive measure. Currently, two vaccines (Ty21a and Vi polysaccharide) are available, but their protective efficacy varies. Improved sanitation and safe food practices are also essential in preventing enteric fever.
Enteric fever continues to pose significant challenges due to diagnostic limitations and antimicrobial resistance. An integrated approach, encompassing accurate diagnosis, appropriate antimicrobial therapy, supportive care, and preventive measures, is crucial. Further research is needed to develop more effective diagnostic tools, therapeutic strategies, and vaccines to combat this persistent global health threat.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation